nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Benign ethnic neutropenia
|
Atallah-Yunes, Suheil Albert |
|
2019 |
37 |
C |
p. |
artikel |
2 |
Cellular therapy for acute myeloid Leukemia – Current status and future prospects
|
Hansrivijit, Panupong |
|
2019 |
37 |
C |
p. |
artikel |
3 |
Challenges of blood transfusions in β-thalassemia
|
Shah, Farrukh T. |
|
2019 |
37 |
C |
p. |
artikel |
4 |
From clonal hematopoiesis to myeloid leukemia and what happens in between: Will improved understanding lead to new therapeutic and preventive opportunities?
|
Bewersdorf, Jan Philipp |
|
2019 |
37 |
C |
p. |
artikel |
5 |
Genotype-phenotype associations in Fanconi anemia: A literature review
|
Fiesco-Roa, Moisés O. |
|
2019 |
37 |
C |
p. |
artikel |
6 |
Indications and potential pitfalls of anticoagulants in pulmonary hypertension: Would DOACs become a better option than VKAs?
|
Margelidon-Cozzolino, Victor |
|
2019 |
37 |
C |
p. |
artikel |
7 |
Platelet activation markers in evaluation of thrombotic risk factors in various clinical settings
|
Kannan, Meganathan |
|
2019 |
37 |
C |
p. |
artikel |
8 |
Sickle cell disease: Clinical presentation and management of a global health challenge
|
Houwing, M.E. |
|
2019 |
37 |
C |
p. |
artikel |
9 |
Thalassemia and malignancy: An emerging concern?
|
Hodroj, Mohammad Hassan |
|
2019 |
37 |
C |
p. |
artikel |
10 |
Therapy-related acute lymphoblastic leukemia: Where do we stand with regards to its definition and characterization?
|
Aldoss, Ibrahim |
|
2019 |
37 |
C |
p. |
artikel |
11 |
Update on mutations in the HIF: EPO pathway and their role in erythrocytosis
|
Lappin, Terence R. |
|
2019 |
37 |
C |
p. |
artikel |
12 |
Use of novel therapies in the treatment of light chain amyloidosis
|
Varga, Cindy |
|
2019 |
37 |
C |
p. |
artikel |